🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
Login

News on Medial

Cancer care startup Oncare raises Rs 27 Cr in Series A round

EntrackrEntrackr · 23h ago
Cancer care startup Oncare raises Rs 27 Cr in Series A round
Medial

Cancer care startup Oncare has raised Rs 27 crore (around $4 million) in a Series A funding round led by Sky Impact Capital. The round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX, and Tremis Capital. Oncare had previously raised $1 million in its seed round led by Huddle Ventures and others. The proceeds will be used to expand into new metro markets as well as tier-II and tier-III cities. The firm will also invest in technology infrastructure to streamline clinical operations, strengthen care coordination, and improve patient experience. Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare operates a distributed oncology care platform focused on affordable and standardized cancer treatment. The firm integrates medical, surgical, and radiation oncology services within accredited hospitals under a capital-efficient model. Oncare currently operates four centers across Delhi NCR. Funding deals in the oncology segment have picked up over the past few years. Recently, 4baseCare raised Rs 90 crore in a round led by Ashish Kacholia and Lashit Sanghvi. Last year, Everhope Oncology secured $10 million in seed funding, while MOC Cancer Care & Research Centre raised $18 million in a round led by Elevation Capital. Other funded startups in the segment include ErlySign, Oncare, and OneCell Diagnostics.

1

Related News

Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi

EntrackrEntrackr · 28d ago
Oncology startup 4baseCare raises Rs 90 Cr led by Ashish Kacholia and Lashit Sanghvi
Medial

Precision oncology startup 4baseCare has raised Rs 90 crore ($9.8 million) in the first close of its Series B round co-led by Ashish Kacholia and Lashit Sanghvi, with participation from existing investor Yali Capital. The new round comes after a gap of two years. In 2024, the company had raised $6 million in Series A funding, led by Yali Capital, with participation from Infosys. The fresh capital will be used to expand 4baseCare’s hospital-linked genomics lab network across India, the Middle East, Southeast Asia, Latin America, and Central Asia. It will also scale its AI-powered precision oncology platform, OncoTwin, which supports clinical decision-making for cancer treatment. Founded by Hitesh Goswami, 4baseCare focuses on building population-relevant clinico-genomic datasets to improve cancer diagnosis and treatment outcomes in underrepresented populations. Its platform integrates genomic testing with real-world clinical and outcomes data to generate actionable insights for oncologists. The OncoTwin platform was recently selected for the MSK iHub program at Memorial Sloan Kettering Cancer Center, New York. The company works closely with hospitals to offer genomics-led cancer diagnostics within clinical settings and is positioning itself to scale across emerging markets. Investor interest in cancer-focused startups has picked up in recent years. Last year, Everhope Oncology raised $10 million in seed funding, and MOC Cancer Care & Research Centre secured $18 million led by Elevation Capital. ErlySign, OnCare, and OneCell Diagnostics are also among the funded startups.

Oncare bags $1 Mn in seed round led by Huddle Ventures

EntrackrEntrackr · 1y ago
Oncare bags $1 Mn in seed round led by Huddle Ventures
Medial

Oncare, a cancer care startup, has raised $1 million in its seed round led by Huddle Ventures. The round also saw participation from marquee institutional VCs such as TRTL Ventures, Cloud Capital, and DeVC. The proceeds will be used to expand its operations to 10 new centres across Delhi NCR, Bangalore, and Jaipur over the next two years. The funds will also be channelled towards team expansion and marketing efforts to raise awareness about the brand’s affordable cancer care solutions. Founded in 2023 by Deepak Kumar and Amar Sneh, Oncare is partnering with 50-100 bedded hospitals to create dedicated oncology wings. Through these partnerships, Oncare is reducing treatment costs by up to 40%. The brand claims to offer an affordable yet high-quality alternative to the expensive cancer treatment—often exceeding Rs 10 lakh in corporate hospitals. It also offers on-call nursing support to help patients manage side effects and anxiety associated with cancer therapies, without having to make unnecessary hospital visits. The startup is operational in South Delhi for the past 10 months and it has provided over 2,500 patients with guidance on treatment plans and claims to have completed over 500 treatment sessions. According to the annual Health of Nation report by Apollo Hospitals, the cancer burden in India is staggering, with yearly cases expected to rise from 1.39 million in 2020 to 1.57 million by 2025. However, high treatment costs, limited availability of oncology centres, and a shortage of specialised professionals are making cancer care inaccessible to millions.

Kites Senior Care raises Rs 45 Cr in Series A round

EntrackrEntrackr · 1y ago
Kites Senior Care raises Rs 45 Cr in Series A round
Medial

Agetech startup Kites Senior Care has raised Rs 45 crore ($5.4 million) in its Series A round led by Ranjan Pai, chairman of Manipal Education and Medical Group (MEMG) through his family office. Previously in January 2023, Kites had raised Rs 14 crore in a pre-series A round from Ranjan Pai. The proceeds will be used to deepen its presence in cities like Bengaluru, Hyderabad, Chennai, while also facilitating expansion into three additional cities across Southern India, the company said in a press release. Founded in 2016 by Rajagopal and Reema, Kites Senior Care specialises in a range of geriatric services including post-operative and post-hospitalisation rehabilitative care, palliative care, dementia care, and respite care, both within care facilities and at the residences of senior citizens. Currently, the startup has a team of 400 care professionals, which is expected to grow to over 1,500. Further, the Bengaluru-based firm has plans to use the newly raised capital to augment its bed capacity to over 1,000 within the next six quarters, up from the current number of 340. Also, it aims to complete the pilot expansion of its tech platform ‘seniorshield,’ leveraging wearable technology from Titan Fastrack. Besides Kites Senior Care, Samarth Life, Age Care Labs, Goodfellows, KareWise, SeniorWorld, GetSetUp, 60Plus India, ElderAid Wellness and GenWise also operate in the agetech space.

Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr

EntrackrEntrackr · 1y ago
Exclusive: Kiran Mazumdar Shaw’s Immuneel Therapeutics raises Rs 100 Cr
Medial

Cancer focused biotech startup Immuneel Therapeutics has raised Rs 100 crore or $12 million in the extension of Series A round from Taiba Middle East FZ LLC. This is the third round of investment for the Bengaluru-based company since its inception in 2018. The board at Immuneel Therapeutic has passed a special resolution to issue 1o equity shares and 8,164 Series A1 CCPS at an issue price of Rs 1,22,330 each to raise Rs 100 crore or $12 million, its regulatory filing accessed from the Registrar of Companies show. The company will use these investments for growth and expansion as decided by the board, the filings further added. As per TheKredible’s estimates, the firm has been valued at around Rs 587 crore or $71 million (post-allotment). Following the fresh proceeds, Taiba Middle East FZ holds a 17% stake in Immuneel Therapeutics. The round appears to be ongoing and it may raise more funds. The company has raised around $40 million to date including its $15 million Series A financing co-led by Eight Roads Ventures, True North, and F-Prime Capital in 2022. Founded by Biocon founder Kiran Mazumdar Shaw, oncologist and Pulitzer winner — Siddhartha Mukherjee and Kush Parwar, Immuneel Therapeutics is an Indian clinical-stage startup which is engaged in developing cell and gene therapies for cancer patients. It’s also working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular immunotherapies for management and treatment of cancer. The firm claims to offer therapies at one-third of the costs borne for gene therapies in America. While the company is yet to file its annual statements for FY24, six-year-old Immuneel Therapeutics remained at a pre-revenue stage in FY23. Its losses stood at Rs 39 crore in the fiscal year ending March 2023.

Healthtech startup Docplix raises Rs 1.2 Cr in bridge round

EntrackrEntrackr · 1y ago
Healthtech startup Docplix raises Rs 1.2 Cr in bridge round
Medial

Healthtech startup Docplix has raised Rs 1.2 crore in its bridge round led by Inflection Point Ventures. Earlier in March this year, DocPlix had raised Rs 5 crore in its pre-Series A round led by Eris Lifesciences with the participation of other angel investors. In February 2022, it raised Rs 1.2 crore in seed round. The fresh proceeds will be used for product development, AI integration, and market expansion, Docplix said in a press release. This will involve enhancing its EHR system, incorporating advanced AI capabilities to improve decision support and patient care, and expanding its market reach. Founded by Varun Garg, Aayush Garg, DocPlix’s ABDM-compliant Electronic Health Record (EHR) system ensures secure and interoperable management of patient data. Its integrated Decision Support System (DSS) helps healthcare professionals make informed decisions through data analytics. Additionally, innovative visualization tools make patient data easy to understand, enhancing patient care and clinic efficiency. The startup claims to serve over 2,000 doctors, extending its reach through programs and remote clinics in tier-II and tier-III cities to address healthcare needs in underserved areas.

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia

EntrackrEntrackr · 1y ago
ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia
Medial

ErlySign raises $1.8 Mn in pre-Series A round from Ashish Kacholia Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia. The proceeds will be used in clinical trials, securing CDSCO (Central Drugs Standard Control Organisation) approvals, and bringing ErlySign’s oral cancer detection kit to market. Founded in 2019 by Shubhendra Singh Thakur and Deovrat Begde, ErlySign develops solutions for early detection of oral cancer. The startup also claims to offer India’s first salivary biomarker-based test which can identify pre-cancerous conditions much before visible symptoms emerge. Looking ahead, ErlySign plans to use CRISPR miRNA-based testing technology to detect multiple types of cancer using the same saliva sample within 15–20 minutes.

Innovist raises Rs 136 Cr led by ICICI Venture; Accel exits

EntrackrEntrackr · 10m ago
Innovist raises Rs 136 Cr led by ICICI Venture; Accel exits
Medial

Innovist, the parent company of Bare Anatomy, has raised Rs 136 crore (approximately $16 million) in a Series B funding round led by ICICI Venture. The round saw participation from Mirabilis Investment Trust, Niveshaay Investment, and existing backer Sauce. The funding round includes both primary and secondary components and will be directed toward product development, business growth, and team expansion, the company said in a media release. In the round, the company provided exit to Accel, which came in via their seed program (atoms). Rohit Chawla, founder and CEO, said that Innovist is one of the fastest-growing BPC (beauty and personal care) firms in the country and aims to cross Rs 300 crore in revenue by FY25. While the company has not yet filed its annual statements for FY24, it reported operational revenue of Rs 36.53 crore in FY23, along with a loss of Rs 16.87 crore. Innovist, previously known as Onesto Labs, was founded in 2018 by Chawla, Sifat Khurana, and Vimal Bhola. The company provides personal care products and currently manages three brands: Bare Anatomy, Chemist at Play, and Sunscoop. To date, Innovist has raised over $26 million, including a $7 million Series A round led by the Amazon Smbhav Venture Fund. According to startup data platform TheKredible, prior to this round, Sauce.VC was the largest external stakeholder, followed by 72 Ventures, Accel India, and the Amazon Smbhav Fund. It competes with D2C beauty brands like Minimalist, Mamaearth, Wow Skin Science, and Sugar Cosmetics.

Medtech startup MedVital raises Rs 8.4 Cr in pre-seed round

EntrackrEntrackr · 9m ago
Medtech startup MedVital raises Rs 8.4 Cr in pre-seed round
Medial

Medtech startup MedVital raises Rs 8.4 Cr in pre-seed round MedVital, a medtech startup focused on skin repair and wound care, has raised Rs 8.4 crore in its pre-seed round led by Nihar Parikh’s 4point0 Health Ventures. The round saw participation from founders of Tata 1mg, NephroPlus, SafeExpress, Eye Q Hospital, Hexa Health, and AstroTalk. The proceeds will be used to expand MedVital’s product portfolio, strengthen its supply chain, and broaden its distribution network to cover hospitals, clinics, and home-care settings. Co-founded by Varun Gupta and Tarun Bansal, MedVital is a full-stack platform for wound care and minimally invasive aesthetics, integrating monitoring and next-generation biomaterials. MedVital’s flagship product, NoWound, is a negative pressure wound therapy (NPWT) device designed for controlled healing of complex wounds. The device is compact, digitally enabled, and locally manufactured. The startup plans to introduce liquid chitosan-based dressings and expand into dermal and hair regeneration solutions.

Download the medial app to read full posts, comements and news.